These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24313827)

  • 1. Nanoliposome-based antibacterial drug delivery.
    Hallaj-Nezhadi S; Hassan M
    Drug Deliv; 2015; 22(5):581-9. PubMed ID: 24313827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes as delivery systems for antibiotics.
    Drulis-Kawa Z; Dorotkiewicz-Jach A
    Int J Pharm; 2010 Mar; 387(1-2):187-98. PubMed ID: 19969054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms.
    Forier K; Raemdonck K; De Smedt SC; Demeester J; Coenye T; Braeckmans K
    J Control Release; 2014 Sep; 190():607-23. PubMed ID: 24794896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal drug delivery systems--clinical applications.
    Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
    Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication of methicillin-resistant Staphylococcus aureus infection by nanoliposomes loaded with gentamicin and oleic acid.
    Atashbeyk DG; Khameneh B; Tafaghodi M; Fazly Bazzaz BS
    Pharm Biol; 2014 Nov; 52(11):1423-8. PubMed ID: 25026343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes for Antibiotic Encapsulation and Delivery.
    Gonzalez Gomez A; Hosseinidoust Z
    ACS Infect Dis; 2020 May; 6(5):896-908. PubMed ID: 32208673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid nanoparticles for oral antimicrobial drug delivery: a review.
    Raza A; Sime FB; Cabot PJ; Maqbool F; Roberts JA; Falconer JR
    Drug Discov Today; 2019 Mar; 24(3):858-866. PubMed ID: 30654055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug delivery system for infectious diseases].
    Maesaki S; Kohno S
    Nihon Rinsho; 1998 Mar; 56(3):752-61. PubMed ID: 9549369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome-Based Antibacterial Delivery: An Emergent Approach to Combat Bacterial Infections.
    Ghosh R; De M
    ACS Omega; 2023 Oct; 8(39):35442-35451. PubMed ID: 37810644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal antibiotics for the treatment of infectious diseases.
    Alhariri M; Azghani A; Omri A
    Expert Opin Drug Deliv; 2013 Nov; 10(11):1515-32. PubMed ID: 23886421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of liposomal drug delivery.
    Szoka FC
    Biotechnol Appl Biochem; 1990 Oct; 12(5):496-500. PubMed ID: 2288703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal drug delivery strategies to eradicate bacterial biofilms: Challenges, recent advances, and future perspectives.
    Panthi VK; Fairfull-Smith KE; Islam N
    Int J Pharm; 2024 Apr; 655():124046. PubMed ID: 38554739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy.
    Moreno-Sastre M; Pastor M; Salomon CJ; Esquisabel A; Pedraz JL
    J Antimicrob Chemother; 2015 Nov; 70(11):2945-55. PubMed ID: 26203182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery systems to increase the selectivity of antibiotics in phagocytic cells.
    Briones E; Colino CI; Lanao JM
    J Control Release; 2008 Feb; 125(3):210-27. PubMed ID: 18077047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial lipids in nano-carriers for antibacterial delivery.
    Zhang Q; Wu W; Zhang J; Xia X
    J Drug Target; 2020 Mar; 28(3):271-281. PubMed ID: 31613147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental osteomyelitis by liposomal antibiotics.
    Kadry AA; Al-Suwayeh SA; Abd-Allah AR; Bayomi MA
    J Antimicrob Chemother; 2004 Dec; 54(6):1103-8. PubMed ID: 15486079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.